CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM
Circulating tumor cells (CTCs) are promising diagnostic and prognostic tools for clinical use. In several cancers, including colorectal and breast, the CTC load has been associated with a therapeutic response as well as progression-free and overall survival. However, counting and isolating CTCs rema...
Main Authors: | Guillaume Belthier, Zeinab Homayed, Fanny Grillet, Christophe Duperray, Julie Vendrell, Ilona Krol, Sophie Bravo, Jean-Christophe Boyer, Olivia Villeronce, Jihane Vitre-Boubaker, Diana Heaug-Wane, Françoise Macari-Fine, Jai Smith, Matthieu Merlot, Gérald Lossaint, Thibault Mazard, Fabienne Portales, Jérôme Solassol, Marc Ychou, Nicola Aceto, Emilie Mamessier, François Bertucci, Jean Marc Pascussi, Emmanuelle Samalin, Frédéric Hollande, Julie Pannequin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/19/4966 |
Similar Items
-
EpCAM as Modulator of Tissue Plasticity
by: François Fagotto
Published: (2020-09-01) -
Complete Loss of EPCAM Immunoexpression Identifies <i>EPCAM</i> Deletion Carriers in MSH2-Negative Colorectal Neoplasia
by: Míriam Cuatrecasas, et al.
Published: (2020-09-01) -
Targeted EpCAM-binding for the development of potent and effective anticancer proteins
by: Zhao Liu, et al.
Published: (2023-05-01) -
Current View on EpCAM Structural Biology
by: Aljaž Gaber, et al.
Published: (2020-05-01) -
Evolution of Thyroglobulin Loop Kinetics in EpCAM
by: Serena H. Chen, et al.
Published: (2021-09-01)